Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OncoSec Medical Incorporated
  6. News
  7. Summary
    ONCS   US68234L3069

ONCOSEC MEDICAL INCORPORATED

(ONCS)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
0.7409 USD   -0.28%
07/12ONCOSEC MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/24Novel pre-clinical results regarding OncoSec's intratumoral electroporation platform were highlighted as Editor's Pick in Molecular Cancer Research
PR
06/14ONCOSEC MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OncoSec Medical Names Robert Arch CEO; Shares Rise Early

04/29/2022 | 05:10pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
GSK PLC 3.57% 1450 Delayed Quote.-14.82%
NOVARTIS AG -1.16% 80.1 Delayed Quote.0.95%
ONCOSEC MEDICAL INCORPORATED -0.28% 0.7409 Delayed Quote.-22.57%
PFIZER, INC. 3.77% 50.11 Delayed Quote.-18.22%
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.42% 3798 Delayed Quote.20.56%
All news about ONCOSEC MEDICAL INCORPORATED
07/12ONCOSEC MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/24Novel pre-clinical results regarding OncoSec's intratumoral electroporation platform we..
PR
06/14ONCOSEC MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
06/14OncoSec Medical Incorporated Reports Earnings Results for the Third Quarter and Nine Mo..
CI
06/09ONCOSEC MEDICAL INC : Other Events (form 8-K)
AQ
06/09OncoSec Medical Incorporated Appoints Joon Kim to the Audit Committee
CI
06/03ONCOSEC MEDICAL INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule o..
AQ
05/23OncoSec Receives Triple Negative Breast Cancer Foundation's Vanguard Award for Excellen..
PR
04/29OncoSec Medical Names Robert Arch CEO; Shares Rise Early
MT
04/29ONCOSEC MEDICAL INCORPORATED : Appoints Dr. Robert Arch as President and Chief Executive O..
PU
More news
Analyst Recommendations on ONCOSEC MEDICAL INCORPORATED
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -35,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,82x
Yield 2022 -
Capitalization 29,2 M 29,2 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 56
Free-Float 44,1%
Chart ONCOSEC MEDICAL INCORPORATED
Duration : Period :
OncoSec Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONCOSEC MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,74 $
Average target price 5,00 $
Spread / Average Target 575%
EPS Revisions
Managers and Directors
Robert H. Arch President & Chief Executive Officer
George Chi Chief Financial Officer
Linda Shi Chairman
Sandra Aung Chief Clinical Development Officer & Senior VP
Keir Loiacono Chief Compliance Officer & Vice President-Legal
Sector and Competitors
1st jan.Capi. (M$)
ONCOSEC MEDICAL INCORPORATED-22.57%29
MODERNA, INC.-32.35%67 212
LONZA GROUP AG-23.32%46 073
IQVIA HOLDINGS INC.-14.23%45 135
SEAGEN INC.12.57%32 099
ALNYLAM PHARMACEUTICALS, INC.35.27%27 533